Manali Kamdar
Associate Professor, Clinical Director of Lymphoma Services
University of Colorado · Aurora, United States
Lymphoma specialist at University of Colorado investigating novel therapies for MCL including CAR-T and bispecific antibodies.
Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma.
Blood advances · Feb 24, 2026
Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis.
Blood advances · Nov 11, 2025
Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma.
Nature communications · Nov 5, 2025
Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · Apr 1, 2024